Título: | MEDICAL DIAGNOSTICS AND COVID-19: THE INNOVATION IN GRUPO FLEURY BUSINESS MODEL | ||||||||||||
Autor(es): |
DOUGLAS SILVA FARIAS |
||||||||||||
Colaborador(es): |
MARTIM FRANCISCO DE OLIVEIRA E SILVA - Orientador |
||||||||||||
Catalogação: | 03/AGO/2023 | Língua(s): | PORTUGUESE - BRAZIL |
||||||||||
Tipo: | TEXT | Subtipo: | SENIOR PROJECT | ||||||||||
Notas: |
[pt] Todos os dados constantes dos documentos são de inteira responsabilidade de seus autores. Os dados utilizados nas descrições dos documentos estão em conformidade com os sistemas da administração da PUC-Rio. [en] All data contained in the documents are the sole responsibility of the authors. The data used in the descriptions of the documents are in conformity with the systems of the administration of PUC-Rio. |
||||||||||||
Referência(s): |
[pt] https://www.maxwell.vrac.puc-rio.br/projetosEspeciais/TFCs/consultas/conteudo.php?strSecao=resultado&nrSeq=63518@1 [en] https://www.maxwell.vrac.puc-rio.br/projetosEspeciais/TFCs/consultas/conteudo.php?strSecao=resultado&nrSeq=63518@2 |
||||||||||||
DOI: | https://doi.org/10.17771/PUCRio.acad.63518 | ||||||||||||
Resumo: | |||||||||||||
The present work focuses on Grupo Fleury., a privately held company with a multibrand business in Brazil, which offers medical diagnostics services. The company faces a challenge of growth and innovation. The work begins with an analysis of the Brazilian healthcare system, its tendencies, companies distribution,and the covid-19 pandemic impact. It then analyzed Grupo Fleury s strategic planand how it can be described based on Porter s five forces to understand the main changes in the sector. Finally, a new business model has been proposed to support Grupo Fleury s competitivity and differentiation on future scenarios.
|
|||||||||||||
|